cupure logo
heres2025topweekoctobernetflixtrumpdealfreeshows

Insilico CEO Alex Zhavoronkov Shares His Vision for ‘Pharma Superintelligence’

Alex Zhavoronkov, founder and CEO of Insilico Medicine, explores how A.I. is driving drug discovery breakthroughs—and transforming the way medicines are discovered, tested and delivered. Zhavoronkov shares his vision for “pharma superintelligence,” where A.I. not only supports but directs decision-making in drug development. When paired with rigorous clinical validation, generative models in biomedicine can compress years of research into months.

Comments

Business News